NCT03131050View on ClinicalTrials.gov

Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

March 15, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

March 8, 2018

Conditions
Major Depressive Disorder
Interventions
DRUG

Scopolamine

Intramuscular injection with scopolamine (0.3 mg/1ml,QD or Bid) during the first three days;

DRUG

Escitalopram

Oral escitalopram 10 mg/d throughout the total of 4 weeks treatment

DRUG

Saline

Intramuscular injection with saline (1ml, QD or Bid) during the first three days;

Trial Locations (1)

Unknown

Beijing Anding Hospital, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER

NCT03131050 - Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD | Biotech Hunter | Biotech Hunter